Media coverage
1
Media coverage
Title VIDEO: Sitravatinib plus nivolumab does not offer OS benefit over docetaxel in NSCLC subset Media name/outlet Healio Country/Territory United States Date 11/14/23 URL https://www.healio.com/news/hematology-oncology/20231114/video-sitravatinib-plus-nivolumab-does-not-offer-os-benefit-over-docetaxel-in-nsclc-subset Persons Hossein Borghaei